HCA Trading Analysis - 11/03/2026 03:53 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below:

• HCA Healthcare reported steady Q3 patient volume growth amid ongoing labor cost pressures in the US hospital sector (recent earnings context).
• Medicare reimbursement rate proposals for the upcoming fiscal year have drawn attention from hospital operators including HCA.
• Industry surveys indicate rising outpatient utilization, a potential margin tailwind for large hospital networks.
• HCA's ex-dividend date is scheduled for 2026-12-15 per fundamentals data, a known near-term shareholder event.
• Broad healthcare sector rotation has been observed as investors weigh defensive exposure in late 2026.

Context: Headlines around labor costs and reimbursement may explain cautious options positioning despite firm technicals. The ex-dividend date aligns with the next major options expiration (2026-12-18) and could influence late-December flow.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E is 14.60 with trailing EPS of 32.13; valuation appears modest versus typical healthcare peers, though PEG ratio is unavailable (null).
• Market cap is 97,223,559,100.00 with shares outstanding of 208,892,000.00.
• Dividend yield is 0.67% (rate 3.12), ex-dividend 2026-12-15; low yield suggests income is not primary driver.
• Beta is 0.22, indicating low systemic volatility relative to market.
• 52-week range: low 353.99, high 556.52; current price 469.06 sits in lower-mid region of annual range.
• Institutional ownership 40.71% — moderate external sponsorship.
• Historical volatility 28.15%; average volume 1,294,000.00.
• Revenue growth, margins, ROE, debt/equity, and free cash flow are null — cannot be assessed.
• Analyst target mean and recommendation key are null — no consensus context provided.

Fundamentals show a low-beta, profitable (EPS 32.13), reasonably valued (P/E 14.60) name, but lack of margin/return data limits confirmation. This neutral-to-supportive fundamental base diverges from bearish options sentiment yet aligns with bullish technical structure.

Current Market Position

From daily and minute data: Current price (2026-11-02 close) is 469.06. Last minute bar (2026-11-03 15:25) shows 465.43, indicating slight pullback into Nov 3.

Recent daily action: 30-day high 488.00 (2026-10-27), low 420.00. Price closed 469.06 on 11-02 after intraday low 460.93. Minute bars 11-02 opened 475.34, fell to 463.28 by 09:45, then stabilized; 11-03 traded tight 465.39–465.85 range with declining volume (11,171 at 15:25).

Intraday momentum is flat-to-soft; no strong directional push in final bars.

Technical Analysis

SMA alignment: Price > SMA 5 > SMA 20 > SMA 50 (469.06 > 466.53 > 459.57 > 438.00) — bullish stack, no bearish cross. RSI 53.93 reflects neutral-to-mild bullish momentum. MACD (9.39) above signal (7.51), histogram positive 1.88 — bullish momentum. Bollinger: price within bands, upper 482.67 acts as near-term ceiling. 30-day range: price at 469.06 is ~46% up from low (420.00) to high (488.00).

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-11-03) shows Bearish sentiment.

Call Dollar Volume: 172,050.00 (31.20%) Put Dollar Volume: 378,790.00 (68.80%) Total: 550,840.00

Contracts: 91 calls vs 231 puts. Pure directional conviction favors puts ~2.5:1. This suggests near-term defensive positioning despite bullish technicals — a clear divergence flagged by spread engine ("Divergence detected between technical indicators and options sentiment").

Key Price Levels (Observational Only)